Mimedx (MDXG) Invested Capital (2010 - 2026)

Mimedx's Invested Capital history runs 17 years deep, the most recent figure standing at $242.9 million for Q1 2026.

• In Q1 2026, Invested Capital rose 19.14% year-over-year to $242.9 million; the TTM figure through Mar 2026 stood at $242.9 million (up 19.14% YoY), while the FY2025 annual figure was $274.5 million, up 29.44% from the prior year.
• Invested Capital came in at $242.9 million for Q1 2026 at Mimedx, down from $274.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $274.5 million in Q4 2025 to a low of $29.0 million in Q3 2022.
• A 5-year average of $137.9 million and a median of $170.2 million in 2024 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital plunged 36.51% in 2022 and jumped 529.67% in 2023, its largest moves.
• Mimedx's Invested Capital stood at $30.6 million in 2022, then surged by 529.67% to $192.7 million in 2023, then gained by 10.06% to $212.1 million in 2024, then rose by 29.44% to $274.5 million in 2025, then retreated by 11.51% to $242.9 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $242.9 million, $274.5 million, and $238.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison